Finally, twenty-eight ASCL2 negatively associated genes were predicted in IFN-γ and IFN-α response pathways, which might help us to comprehensively understand the deficient IFN response in MSS samples and contribute to better designing the combination of anticancer drugs and immunotherapies. This evidence concerns the gene ASCL2 and Marinesco-Sjogren syndrome.